Seattle, WA – April 07, 2025 – Reverba, a leader in healthcare engagement, today announced its rebranding as Reverba Global in response to accelerated company growth and international scope. At the heart of this rebranding is expansion of its corporate vision to transform healthcare engagement for better outcomes through a wide range of bespoke, authentic, scientifically rigorous and compliant communications channels and programs.
For nearly 25 years, Reverba (formerly Health Perspectives Group) has partnered with biopharmaceutical companies to foster meaningful connections between patients, caregivers, and healthcare professionals (HCPs) with expert patient recruitment and proprietary technology solutions. Through acquisitions, Reverba Global is strengthening its medical affairs and scientific engagement capabilities, supporting the company’s ability to deliver comprehensive patient engagement and scientific communications solutions touching all aspects of the biopharma product lifecycle – drug development, clinical trials, medical affairs, launch, commercialization and market maturity.
The transition to Reverba Global reflects a new chapter of growth and impact based on the company’s expanded mission to innovate and build connections worldwide, with more than 190 team members in the U.S., Canada and the U.K., serving more than 40 countries and more than 450 disease areas.
“Reverba Global embodies our team’s dedication to accessible and accurate medical information, empowering patients to manage their care and their health,” said Cheryl Lubbert, CEO of Reverba Global. “We know the biopharma marketplace knows no borders, and the patient experience is universal. We strive to be the premier health engagement partner for biopharmaceutical companies, building relationships with patients and HCPs, amplifying patient voices and fostering deeper engagement that drives transformation in healthcare.”
About Reverba Global
Reverba Global is a world-class tech-enabled health engagement company that provides solutions to empower the biopharmaceutical industry to forge deeper, more impactful connections with patients, families, healthcare providers and other key health stakeholders through innovative technology and compliant, patient-centric approaches from discovery through commercialization. Since 2002, Reverba Global has incorporated compliance throughout its technology platforms and healthcare engagement solutions, maintaining SOC 2 Type II certification for the highest level of security. Formed from the mergers of Health Advocacy Strategies, Patient Health Perspectives, and Health Perspectives Group, the company rebranded as Reverba in 2021, and with expansion beyond the U.S. through acquisitions including Six Degrees Worldwide Inc. rebranded as Reverba Global in 2025. Health Stories Project, a wholly owned subsidiary of Reverba Global, is a sharing community about personal health experiences, participation in clinical trials, and other activities.
For more information, visit reverba.com, follow us on LinkedIn or contact connect@reverba.com.
For media inquiries, please contact:
Kira Gordon
Email: kira@brightpointny.com
Phone: (646) 243-4920
